[CITATION][C] Bcr-Abl inhibition as a modality of CML therapeutics.
E Buchdunger, A Matter, BJ Druker - Biochimica et Biophysica Acta, 2001 - europepmc.org
Bcr-Abl inhibition as a modality of CML therapeutics. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us
Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus Search
life-sciences literature (43,669,105 articles, preprints and more) Search Advanced search
Feedback This website requires cookies, and the limited processing of your personal data in
order to function. By using the site you are agreeing to this as outlined in our privacy notice and …
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us
Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus Search
life-sciences literature (43,669,105 articles, preprints and more) Search Advanced search
Feedback This website requires cookies, and the limited processing of your personal data in
order to function. By using the site you are agreeing to this as outlined in our privacy notice and …